Research Article

Primary Tumor Site Affects Survival in Patients with Gastroenteropancreatic and Neuroendocrine Liver Metastases

Table 1

Survival by primary tumor site among patients with NELM.

Location of primary site tumorMedian95% CI

Small intestine1009NR62.6 – NR
Pancreas83352.046.0 – 56.0
Colon20653.738.8 – NR
Rectum7030.717.0 – 49.9
Stomach7031.416.8 – NR